Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Enhanced Recovery After Thoracic Surgery Protocol on Inflammatory Markers

NCT05329311 is registered in ClinicalTrials.gov with Atatürk Chest Diseases and Chest Surgery Training and Research Hospital as lead sponsor.

NCT NCT05329311
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05329311 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Enhanced Recovery After Thoracic Surgery Protocol on Inflammatory Markers
Lead sponsor
Atatürk Chest Diseases and Chest Surgery Training and Research Hospital
Phase
Observational
Overall status
Completed
Start date
March 16, 2022
Completion date
June 16, 2022
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

c-reactive protein, enhanced recovery after thoracic surgery protocol, lymphocyte/monocytes ratio, neutrophil/lymphocyte ratio, plathelet/ lymphocyte ratio, thoracic surgery, white blood cell count